Health
US to widen inquiry into AstraZeneca COVID vaccine destined for Australia – Sydney Morning Herald
The US regulator has broadened its investigation of a serious illness in AstraZeneca’s COVID-19 vaccine study, a development closely watched by local regulators…
AstraZeneca has confirmed it is still awaiting the green light from US regulators to resume its US trials. The pharma giant’s Australian office wouldn’t comment further on how any delays would affect the timeline for when Australians receive the vaccine if successful.
Meanwhile, there was better news for the vaccine in Europe overnight, with reports the European Medicines Agency is expected to announce a “rolling review” of the Oxford/AstraZeneca candidate this week.
This would mean the Europe…
-
General20 hours ago‘Potential’ hacker contacts Qantas over data breach
-
Noosa News6 hours agoHow Lily Steele-Park took her rapist to court and won
-
Business11 hours agoFord CEO makes stunning prediction about artificial intelligence
-
General22 hours agoFears for next anti-Semitic firebombing on home soil